Review



phosphorylated iκb alpha  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Proteintech phosphorylated iκb alpha
    Phosphorylated Iκb Alpha, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 676 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated iκb alpha/product/Proteintech
    Average 96 stars, based on 676 article reviews
    phosphorylated iκb alpha - by Bioz Stars, 2026-02
    96/100 stars

    Images



    Similar Products

    96
    Proteintech phosphorylated iκb alpha
    Phosphorylated Iκb Alpha, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated iκb alpha/product/Proteintech
    Average 96 stars, based on 1 article reviews
    phosphorylated iκb alpha - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc phosphorylated iκb α
    Phosphorylated Iκb α, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated iκb α/product/Cell Signaling Technology Inc
    Average 99 stars, based on 1 article reviews
    phosphorylated iκb α - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology phosphorylated p iκbα
    FGF20 inhibits NF-κB pathway through S100A9 in DDS-induced mice. ( A ) KEGG Enrichment Analysis of proteomics data from the colonic tissue of FGF20 KO and WT mice with or without colitis. ( B ) Immunoblot analysis of colonic p-P65, P65, <t>p-IκBα,</t> and IκBα from FGF20 KO and WT mice with or without colitis (n = 6). ( C ) Immunoblot analysis of colonic p-P65, P65, p-IκBα, and IκBα contents in AAV-FGF20- or AAV-GFP-treated mice with or without colitis. ( D ) Immunoblot analysis of colonic p-P65, P65, p-IκBα, and IκBα contents in FGF20 KO mice and WT mice with colitis, treated with paquinimod or vehicle (n = 6). ( E ) Immunoblot analysis of colonic p-P65, P65, p-IκBα, and IκBα contents in AAV-FGF20-treated mice and AAV-GFP-treated mice with colitis, treated with AAV-S100A9 or not (n = 6). Data are represented as mean ± SEM; ∗ P < .05, ∗∗ P < .01, ∗∗∗ P < .001.
    Phosphorylated P Iκbα, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated p iκbα/product/Santa Cruz Biotechnology
    Average 96 stars, based on 1 article reviews
    phosphorylated p iκbα - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology phosphorylated iκb α
    FGF20 inhibits NF-κB pathway through S100A9 in DDS-induced mice. ( A ) KEGG Enrichment Analysis of proteomics data from the colonic tissue of FGF20 KO and WT mice with or without colitis. ( B ) Immunoblot analysis of colonic p-P65, P65, <t>p-IκBα,</t> and IκBα from FGF20 KO and WT mice with or without colitis (n = 6). ( C ) Immunoblot analysis of colonic p-P65, P65, p-IκBα, and IκBα contents in AAV-FGF20- or AAV-GFP-treated mice with or without colitis. ( D ) Immunoblot analysis of colonic p-P65, P65, p-IκBα, and IκBα contents in FGF20 KO mice and WT mice with colitis, treated with paquinimod or vehicle (n = 6). ( E ) Immunoblot analysis of colonic p-P65, P65, p-IκBα, and IκBα contents in AAV-FGF20-treated mice and AAV-GFP-treated mice with colitis, treated with AAV-S100A9 or not (n = 6). Data are represented as mean ± SEM; ∗ P < .05, ∗∗ P < .01, ∗∗∗ P < .001.
    Phosphorylated Iκb α, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated iκb α/product/Santa Cruz Biotechnology
    Average 96 stars, based on 1 article reviews
    phosphorylated iκb α - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology phosphorylated ikbα
    Western blot analysis of nSMase1 expression (a) and total IkB, <t>phosphorylated</t> IkB, and total/phosphorylated ratio (b). C, control; D, doxorubicin; DW, doxorubicin + omega‐3 fatty acids. pD, value for doxorubicin effect; pW, value for omega‐3 fatty acids effect; pi, value doxorubicin + omega‐3 fatty acids interaction; W, omega‐3 fatty acids. Data are expressed as means ± SD. p , values are from two‐way analysis of variance. *Animals treated with doxorubicin were statistically different from animals not treated with chemotherapy. <t>IkB</t> and p‐IkB were incubated on the same membrane using stripping technique, and the same GADPH was used to normalize both.
    Phosphorylated Ikbα, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated ikbα/product/Santa Cruz Biotechnology
    Average 96 stars, based on 1 article reviews
    phosphorylated ikbα - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    Image Search Results


    FGF20 inhibits NF-κB pathway through S100A9 in DDS-induced mice. ( A ) KEGG Enrichment Analysis of proteomics data from the colonic tissue of FGF20 KO and WT mice with or without colitis. ( B ) Immunoblot analysis of colonic p-P65, P65, p-IκBα, and IκBα from FGF20 KO and WT mice with or without colitis (n = 6). ( C ) Immunoblot analysis of colonic p-P65, P65, p-IκBα, and IκBα contents in AAV-FGF20- or AAV-GFP-treated mice with or without colitis. ( D ) Immunoblot analysis of colonic p-P65, P65, p-IκBα, and IκBα contents in FGF20 KO mice and WT mice with colitis, treated with paquinimod or vehicle (n = 6). ( E ) Immunoblot analysis of colonic p-P65, P65, p-IκBα, and IκBα contents in AAV-FGF20-treated mice and AAV-GFP-treated mice with colitis, treated with AAV-S100A9 or not (n = 6). Data are represented as mean ± SEM; ∗ P < .05, ∗∗ P < .01, ∗∗∗ P < .001.

    Journal: Cellular and Molecular Gastroenterology and Hepatology

    Article Title: Fibroblast Growth Factor 20 Attenuates Colitis by Restoring Impaired Intestinal Epithelial Barrier Integrity and Modulating Macrophage Polarization via S100A9 in an NF-κB-Dependent Manner

    doi: 10.1016/j.jcmgh.2025.101486

    Figure Lengend Snippet: FGF20 inhibits NF-κB pathway through S100A9 in DDS-induced mice. ( A ) KEGG Enrichment Analysis of proteomics data from the colonic tissue of FGF20 KO and WT mice with or without colitis. ( B ) Immunoblot analysis of colonic p-P65, P65, p-IκBα, and IκBα from FGF20 KO and WT mice with or without colitis (n = 6). ( C ) Immunoblot analysis of colonic p-P65, P65, p-IκBα, and IκBα contents in AAV-FGF20- or AAV-GFP-treated mice with or without colitis. ( D ) Immunoblot analysis of colonic p-P65, P65, p-IκBα, and IκBα contents in FGF20 KO mice and WT mice with colitis, treated with paquinimod or vehicle (n = 6). ( E ) Immunoblot analysis of colonic p-P65, P65, p-IκBα, and IκBα contents in AAV-FGF20-treated mice and AAV-GFP-treated mice with colitis, treated with AAV-S100A9 or not (n = 6). Data are represented as mean ± SEM; ∗ P < .05, ∗∗ P < .01, ∗∗∗ P < .001.

    Article Snippet: FGF20 (1/500, SC-373927, Santa CruzA), Bcl2 (1/1000, AB182858, Abcam), Bax (1/1000, AB32503, Abcam), S100A9 (1/500, SC-53187, Santa Cruz), S100A8 (1/500, SC-48352, Santa Cruz), phosphorylated (p) -IκBα (1/500, SC-8404, Santa Cruz), p-P65 (1/500, SC-136548, Santa Cruz), IκBα (1/1000, 4814S, CST, USA), P65 (1/1000, 4814S, CST), TNF-α (1/1000, AF7014, Affinity, China), IL6 (1/1000, 12912S, CST), FGFR1 (1/1000, bs-0230R, Bioss, China), FGFR2 (1/1000, bs-0675R, Bioss), FGFR3 (1/2000, MA5-31142, ThermoFisher), FGFR4 (1/1000, bsm-61509R, Bioss), GAPDH (1/10000, HRP-60004, Proteintech, China), and Beta-Tubulin (1/5000, 10094-1-AP, Proteintech).

    Techniques: Western Blot

    FGF20 inhibits M1-like macrophage polarization in NF-κB-dependent manner in vitro. Primary peritoneal macrophages were isolated from WT mice and FGF20 KO mice and used for subsequent in vitro experiments. ( A ) Immunoblot analysis of expression of iNOS, TNF-α, IL6, S100A9, p-P65, P65, p-IκBα, and IκBα in LPS-stimulated primary peritoneal macrophages, treated with or without BAY11-7082 (n = 3). ( B ) Representative immunofluorescence images and its fluorescence densities of LPS-stimulated primary peritoneal macrophages, treated with or without BAY11-7082 (n = 6). Data are represented as mean ± SEM; ∗∗ P < .01, ∗∗∗ P < .001.

    Journal: Cellular and Molecular Gastroenterology and Hepatology

    Article Title: Fibroblast Growth Factor 20 Attenuates Colitis by Restoring Impaired Intestinal Epithelial Barrier Integrity and Modulating Macrophage Polarization via S100A9 in an NF-κB-Dependent Manner

    doi: 10.1016/j.jcmgh.2025.101486

    Figure Lengend Snippet: FGF20 inhibits M1-like macrophage polarization in NF-κB-dependent manner in vitro. Primary peritoneal macrophages were isolated from WT mice and FGF20 KO mice and used for subsequent in vitro experiments. ( A ) Immunoblot analysis of expression of iNOS, TNF-α, IL6, S100A9, p-P65, P65, p-IκBα, and IκBα in LPS-stimulated primary peritoneal macrophages, treated with or without BAY11-7082 (n = 3). ( B ) Representative immunofluorescence images and its fluorescence densities of LPS-stimulated primary peritoneal macrophages, treated with or without BAY11-7082 (n = 6). Data are represented as mean ± SEM; ∗∗ P < .01, ∗∗∗ P < .001.

    Article Snippet: FGF20 (1/500, SC-373927, Santa CruzA), Bcl2 (1/1000, AB182858, Abcam), Bax (1/1000, AB32503, Abcam), S100A9 (1/500, SC-53187, Santa Cruz), S100A8 (1/500, SC-48352, Santa Cruz), phosphorylated (p) -IκBα (1/500, SC-8404, Santa Cruz), p-P65 (1/500, SC-136548, Santa Cruz), IκBα (1/1000, 4814S, CST, USA), P65 (1/1000, 4814S, CST), TNF-α (1/1000, AF7014, Affinity, China), IL6 (1/1000, 12912S, CST), FGFR1 (1/1000, bs-0230R, Bioss, China), FGFR2 (1/1000, bs-0675R, Bioss), FGFR3 (1/2000, MA5-31142, ThermoFisher), FGFR4 (1/1000, bsm-61509R, Bioss), GAPDH (1/10000, HRP-60004, Proteintech, China), and Beta-Tubulin (1/5000, 10094-1-AP, Proteintech).

    Techniques: In Vitro, Isolation, Western Blot, Expressing, Immunofluorescence, Fluorescence

    Western blot analysis of nSMase1 expression (a) and total IkB, phosphorylated IkB, and total/phosphorylated ratio (b). C, control; D, doxorubicin; DW, doxorubicin + omega‐3 fatty acids. pD, value for doxorubicin effect; pW, value for omega‐3 fatty acids effect; pi, value doxorubicin + omega‐3 fatty acids interaction; W, omega‐3 fatty acids. Data are expressed as means ± SD. p , values are from two‐way analysis of variance. *Animals treated with doxorubicin were statistically different from animals not treated with chemotherapy. IkB and p‐IkB were incubated on the same membrane using stripping technique, and the same GADPH was used to normalize both.

    Journal: Food Science & Nutrition

    Article Title: Omega‐3 supplementation attenuates doxorubicin‐induced cardiotoxicity but is not related to the ceramide pathway

    doi: 10.1002/fsn3.4492

    Figure Lengend Snippet: Western blot analysis of nSMase1 expression (a) and total IkB, phosphorylated IkB, and total/phosphorylated ratio (b). C, control; D, doxorubicin; DW, doxorubicin + omega‐3 fatty acids. pD, value for doxorubicin effect; pW, value for omega‐3 fatty acids effect; pi, value doxorubicin + omega‐3 fatty acids interaction; W, omega‐3 fatty acids. Data are expressed as means ± SD. p , values are from two‐way analysis of variance. *Animals treated with doxorubicin were statistically different from animals not treated with chemotherapy. IkB and p‐IkB were incubated on the same membrane using stripping technique, and the same GADPH was used to normalize both.

    Article Snippet: After electrophoresis, the proteins were transferred to nitrocellulose membrane and incubated with 5% skimmed milk blocking for 1 h. Afterward, the membrane was incubated with nSMase1 primary antibody (ab‐131330, ABCAM, Cambridge, UK), total IkBα (sc‐1643, Santa Cruz Biotechnology, Dallas, TX, USA), and phosphorylated IkBα (sc‐8404, Santa Cruz Biotechnology, Dallas, TX, USA) primary antibody, diluted in TBS / 3% skimmed milk overnight.

    Techniques: Western Blot, Expressing, Control, Incubation, Membrane, Stripping Membranes